DSM Receives FDA Approval of First U.S. Mycotoxin Degrading Ingredient for Poultry

DSM Animal Nutrition and Health — a global science-based company focused on nutrition, health and sustainable living — announced the FDA approval of a novel enzyme, fumonisin esterase, to help poultry producers manage mycotoxins in feed.

Paige Gott, Ph.D., DSM mycotoxin and Hy•D® category manager, said fumonisin esterase is for the degradation of fumonisins present in poultry feed, and this approval expands DSM’s commitment to innovation in mycotoxin management.

“This is the first mycotoxin degrading ingredient to go through FDA’s Food Additive Petition (FAP) process and will be the first product ever to be approved for degrading fumonisins in feed in the U.S. market,” said Gott.

The enzyme is now approved for use in both poultry and swine diets.

“Mycotoxins can have various negative effects on poultry production,” Gott continued. "Since 2014, fumonisins have been detected in 50% to 80% percent of corn samples screened as part of our annual mycotoxin survey. And with high corn prices, it’s imperative right now that feed is working without concern of performance-related losses.”

DSM will offer two new products using the fumonisin esterase enzyme and the brand name FUMzyme®. Biofix® Plus with FUMzyme® and Biofix® Select with FUMzyme® will now be a part of DSM’s mycotoxin product portfolio. More information will be available in the coming weeks.

DSM

Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM’s purpose is to create brighter lives for all. DSM’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at https://www.dsm.com/.

Published on

03 August 2022

Media Contact

Hannah Gardner

Share

You are being redirected.

We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.